Home/Couragene/Amy Liao, PhD

AL

Amy Liao, PhD

Co-Founder, Chief Executive Officer

Therapeutic Areas

Neurological Disorders

Couragene Pipeline

Drug	Indication	Phase
STEP-CRISPR	Proof-of-concept for neurological gene editing	Pre-clinical

Leadership Team at Couragene

Conrad Leung, PhD

Chief Scientific Officer

Jiangbing Zhou, PhD

Co-Founder, Chief Scientific Advisor

Yong-Hui Jiang, MD, PhD

Scientific Co-Founder, Chief Medical Advisor

View full Couragene profile